Moderna This Year: Outperforming Vaccine Stocks So Far
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
This piece reviews index funds that pair well with Roth IRA rollovers, emphasizing broad market exposure and cost efficiency for easier long-term growth.
24,239 articlesModerna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
SpaceX’s IPO buzz is reshaping how traders view tech hardware plays. This story explains why micron stock after space...
As GBTC’s 1.50% fee persists, the cost compounds for long-horizon investors. This piece compares the drag to cheaper ...
When a CEO steps up with a sizable open-market purchase, investors take note. We unpack what McGraw Hill's 22,000-sha...
Futures for major indices fall in early trading as tech names lead declines. Investors weigh rate expectations and in...
Investors chasing a SpaceX IPO windfall risk turning luck into poor strategy. Experts warn the real lesson is risk ma...
In a volatile 2026 market, a defensively positioned dividend stock offers stock ultimate dividend safety. Coca-Cola i...
When a crypto-focused firm makes a substantial equity bet in a media company, it can signal strategic confidence—and ...
A big wave of Iranian crude has hit global markets after Washington opened waivers, potentially adding 130-150 millio...
A major director sale in a blockchain-focused company can raise questions about risk and opportunity. This deep dive ...
As a new Federal Reserve chair makes his debut, Jim Cramer argues markets should expect stability, not shocks. Trader...
The BEA final read confirms economy grew 2.1% first quarter, signaling momentum. Here’s what drove growth and what ho...